Browse the full record of transactions filed by Hoelscher Paul W., Chief Financial Officer. Director active across 1 companies, notably Horizon Therapeutics Public Ltd Co. Aggregated, 13 filings have been logged. Total volume traded: €15.3m. The latest transaction was disclosed on 20 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Hoelscher Paul W. serves as CFO at Horizon Therapeutics Public Ltd Co. He is responsible for the financial management of the company, including budgeting and performance analysis. His expertise is essential for ensuring the financial health and growth of the organization.